Skip to search formSkip to main contentSkip to account menu

xanthenone-4-acetic acid

Known as: 9H-Xanthene-4-acetic acid, 9-oxo-, XOAA 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Background:Species selectivity of DMXAA (5,6-dimethylxanthenone-4-acetic acid, Vadimezan) for murine cells over human cells could… 
2009
2009
In order to proliferate, solid tumours require the development and continuous expansion of an organised host-derived vascular… 
2004
2004
SummaryAlthough the antitumour agent flavone-8-acetic acid (FAA) exhibits remarkable activity against murine solid tumours, its… 
2004
2004
SummaryTreatment of C57Bl/6×DBA/2 mice with the maximal tolerated dose of flavone-8-acetic acid (FAA, 1300 μmol/kg), xanthenone-4… 
1997
1997
SummaryDerivatives of xanthenone-4-acetic acid (XAA) were developed as analogues of flavone-8-acetic acid (FAA), a drug with… 
1992
1992
Derivatives of xanthenone-4-acetic acid (XAA) have been found to have similar activity to flavone-8-acetic acid against… 
1992
1992
A series of 9-oxo-9,10-dihydroacridine-4-acetic acids (acridone-4-acetic acids) were prepared by Jourdan-Ullmann condensation of… 
Highly Cited
1991
Highly Cited
1991
The antitumor agent flavone-8-acetic acid (FAA) is remarkable because it induces hemorrhagic necrosis, altered tumor blood flow…